NEW YORK, Jan. 29, 2007 (PRIME NEWSWIRE) -- The NASDAQ Stock Market announced today that it will delist the ordinary shares of Taro Pharmaceutical Industries, Ltd. Taro Pharmaceutical's stock was suspended on December 14, 2006 and has not traded on NASDAQ since that time. NASDAQ will file a Form 25 with the Securities and Exchange Commission to complete the delisting. The delisting becomes effective ten days after the Form 25 is filed. For news and additional information about the company, including the basis for the delisting and whether the company's securities are trading on another venue, please review the company's public filings or contact the company directly.
For more information about The NASDAQ Stock Market, visit the NASDAQ Web site at http://www.nasdaq.com. NASDAQ's rules governing the delisting of securities can be found in the NASDAQ Rule 4800 Series, available on the NASDAQ Web site: http://www.complinet.com/nasdaq/display/display.html?rbid=1705&element_id=1854.
In This StoryNDAQ
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.